JP2011519932A5 - - Google Patents

Download PDF

Info

Publication number
JP2011519932A5
JP2011519932A5 JP2011508521A JP2011508521A JP2011519932A5 JP 2011519932 A5 JP2011519932 A5 JP 2011519932A5 JP 2011508521 A JP2011508521 A JP 2011508521A JP 2011508521 A JP2011508521 A JP 2011508521A JP 2011519932 A5 JP2011519932 A5 JP 2011519932A5
Authority
JP
Japan
Prior art keywords
nanoparticles
protein
phase solution
aqueous phase
immunogenic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011508521A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011519932A (ja
JP5546532B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2009/002935 external-priority patent/WO2009137112A1/en
Publication of JP2011519932A publication Critical patent/JP2011519932A/ja
Publication of JP2011519932A5 publication Critical patent/JP2011519932A5/ja
Application granted granted Critical
Publication of JP5546532B2 publication Critical patent/JP5546532B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011508521A 2008-05-09 2009-05-11 非免疫原生の疎水性タンパク質ナノ粒子の形成方法、及びその利用 Active JP5546532B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12713408P 2008-05-09 2008-05-09
US61/127,134 2008-05-09
PCT/US2009/002935 WO2009137112A1 (en) 2008-05-09 2009-05-11 Method of forming non-immunogenic hydrophobic protein nanoparticles and uses therefor

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2014099344A Division JP5851550B2 (ja) 2008-05-09 2014-05-13 非免疫原生の疎水性タンパク質ナノ粒子の形成方法、及びその利用

Publications (3)

Publication Number Publication Date
JP2011519932A JP2011519932A (ja) 2011-07-14
JP2011519932A5 true JP2011519932A5 (enExample) 2012-06-28
JP5546532B2 JP5546532B2 (ja) 2014-07-09

Family

ID=41264904

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2011508521A Active JP5546532B2 (ja) 2008-05-09 2009-05-11 非免疫原生の疎水性タンパク質ナノ粒子の形成方法、及びその利用
JP2014099344A Active JP5851550B2 (ja) 2008-05-09 2014-05-13 非免疫原生の疎水性タンパク質ナノ粒子の形成方法、及びその利用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2014099344A Active JP5851550B2 (ja) 2008-05-09 2014-05-13 非免疫原生の疎水性タンパク質ナノ粒子の形成方法、及びその利用

Country Status (11)

Country Link
US (2) US8669225B2 (enExample)
EP (1) EP2285825B1 (enExample)
JP (2) JP5546532B2 (enExample)
KR (1) KR101616771B1 (enExample)
CN (1) CN102066399B (enExample)
AU (1) AU2009244742B2 (enExample)
BR (1) BRPI0908686B8 (enExample)
CA (1) CA2723563C (enExample)
IL (1) IL209155A (enExample)
RU (1) RU2010146684A (enExample)
WO (1) WO2009137112A1 (enExample)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2691531C (en) 2007-06-22 2016-11-01 Board Of Regents,The University Of Texas System Formation of stable submicron peptide or protein particles by thin film freezing
KR101616771B1 (ko) * 2008-05-09 2016-04-29 사우스다코타주립대학 비면역원성의 소수성 단백질 나노입자의 형성방법 및 그 용도
US8697098B2 (en) 2011-02-25 2014-04-15 South Dakota State University Polymer conjugated protein micelles
US20140234420A1 (en) * 2008-05-09 2014-08-21 Omathanu P. Perumal Method of Treating Skin Disorders using Nanoscale Delivery Devices and Transdermal Enhancing Compositions
WO2010056657A2 (en) 2008-11-16 2010-05-20 Board Of Regents, The Univesity Of Texas System Low viscosity highly concentrated suspensions
BR112012033806B1 (pt) 2010-06-30 2019-10-15 Unilever N.V. Composição na forma de partícula compreendendo polímero hidrofóbico e composto fenólico, método para preparação da composição e uso da composição
PL2594140T3 (pl) * 2010-07-16 2019-09-30 Universidad De Navarra Nanocząstki do kapsułkowania związków, ich wytwarzanie i zastosowanie
CN102120823B (zh) * 2011-01-06 2016-08-03 鲁传华 水溶性玉米朊的合成及在药物制剂中的运用
JP2014518842A (ja) 2011-02-25 2014-08-07 サウス ダコタ ステート ユニバーシティー ポリマーコンジュゲートタンパク質ミセル
EP2678007A4 (en) * 2011-02-25 2015-08-12 Univ South Dakota PROTEIN NANOTRIER FOR TOPICAL ADMINISTRATION
WO2012122544A2 (en) * 2011-03-10 2012-09-13 Board Of Regents, The University Of Texas System Protein nanoparticle dispersions
CN104203092A (zh) * 2011-08-26 2014-12-10 维科纳米医药有限公司 病原体和物质陷阱
EP2625966A1 (en) 2012-02-13 2013-08-14 Bionanoplus, S.L. Nanoparticles comprising a vegetable hydrophobic protein and a water miscible non-volatile organic solvent and uses thereof
WO2014005299A1 (en) * 2012-07-04 2014-01-09 Empire Technology Development Llc Quantum dot-protein complexes, films, and methods of use
KR102045732B1 (ko) * 2012-12-28 2019-11-18 엘지디스플레이 주식회사 온도감응형 계면활성제를 이용한 수용성 나노입자의 제조방법
US20150150822A1 (en) * 2013-06-04 2015-06-04 South Dakota State University Novel core-shell nanoparticles for oral drug delivery
IL228528A (en) 2013-09-17 2015-01-29 Technion Res & Dev Foundation Potato-based nanoparticles
WO2016057799A1 (en) * 2014-10-09 2016-04-14 Therakine Use of meso-and nanoporous material for surfactant trapping in nanoparticle suspensions
WO2018071864A1 (en) 2016-10-13 2018-04-19 Thomas Jefferson University Delivery compositions, and methods of making and using same
JP7169671B2 (ja) 2017-06-02 2022-11-11 テイカ製薬株式会社 難水溶性成分可溶化ミセル及びそれを含有する液剤
TWI642685B (zh) * 2017-07-26 2018-12-01 中原大學 新穎胜肽及其應用
CN109432433A (zh) * 2018-10-30 2019-03-08 中国药科大学 一种纳米载体的制备方法和用途
CN109730976B (zh) * 2018-12-24 2020-06-09 华中科技大学 一种基于自由基氧化制备白蛋白纳米粒的方法
CN110251487B (zh) * 2019-08-01 2021-11-02 郑州大学 一种提高多西他赛载药量和口服生物利用度的醇溶蛋白纳米粒的制备方法及其应用
CN112121019B (zh) * 2020-09-23 2022-05-31 合肥工业大学 抗氧化型淀粉基糊精复合纳米颗粒及其制备方法与应用
CN115025054B (zh) * 2022-06-09 2023-12-22 四川普锐特药业有限公司 一种以乳铁蛋白为载体的纳米组合物的制备方法
CN116998582A (zh) * 2023-08-08 2023-11-07 扬州大学 一种高溶解度油料植物蛋白的制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2236521A (en) 1937-08-12 1941-04-01 Zein Corp Of America Ink
US5330778A (en) 1988-09-19 1994-07-19 Opta Food Ingredients, Inc. Hydrophobic protein microparticles
WO1991006287A1 (en) 1989-11-06 1991-05-16 Enzytech, Inc. Protein microspheres and methods of using them
US5254673A (en) 1991-12-26 1993-10-19 Opta Food Ingredients, Inc. Purification of zein from corn gluten meal
IE80468B1 (en) * 1995-04-04 1998-07-29 Elan Corp Plc Controlled release biodegradable nanoparticles containing insulin
MY153295A (en) * 2004-09-29 2015-01-29 Nestec Sa Nanoparticulated whey proteins
US20070148251A1 (en) 2005-12-22 2007-06-28 Hossainy Syed F A Nanoparticle releasing medical devices
CN101415395B (zh) * 2006-03-29 2012-02-08 富士胶片株式会社 酪蛋白纳米粒子
WO2008013785A2 (en) * 2006-07-24 2008-01-31 Singh-Broemer And Company, Inc. Solid nanoparticle formulation of water insoluble pharmaceutical substances with reduced ostwald ripening
CN101485629B (zh) * 2008-01-16 2013-01-23 沈阳药科大学 一种给药系统及其制备方法
KR101616771B1 (ko) * 2008-05-09 2016-04-29 사우스다코타주립대학 비면역원성의 소수성 단백질 나노입자의 형성방법 및 그 용도
EP2678007A4 (en) * 2011-02-25 2015-08-12 Univ South Dakota PROTEIN NANOTRIER FOR TOPICAL ADMINISTRATION

Similar Documents

Publication Publication Date Title
Mikušová et al. Advances in chitosan-based nanoparticles for drug delivery
RU2010146684A (ru) Способ получения неиммуногенных гидрофобных белковых наночастиц и их применения
Iacob et al. Recent biomedical approaches for chitosan based materials as drug delivery nanocarriers
Kyriakides et al. Biocompatibility of nanomaterials and their immunological properties
Sonvico et al. Surface-modified nanocarriers for nose-to-brain delivery: from bioadhesion to targeting
Jia et al. In vitro and in vivo evaluation of paclitaxel-loaded mesoporous silica nanoparticles with three pore sizes
Yu et al. Influence of geometry, porosity, and surface characteristics of silica nanoparticles on acute toxicity: their vasculature effect and tolerance threshold
Nojoki et al. Design and development of chitosan-insulin-transfersomes (Transfersulin) as effective intranasal nanovesicles for the treatment of Alzheimer’s disease: In vitro, in vivo, and ex vivo evaluations
Chen et al. Advances in antitumor nano-drug delivery systems of 10-hydroxycamptothecin
Paliwal et al. Biomimetic solid lipid nanoparticles for oral bioavailability enhancement of low molecular weight heparin and its lipid conjugates: in vitro and in vivo evaluation
Chhabra et al. Emerging use of nanotechnology in the treatment of neurological disorders
CN106177986A (zh) 一种脂质体‑聚合物载药纳米粒子及其制备方法和应用
Jampílek et al. Nanotechnology-based formulations for drug targeting to the central nervous system
Dimer et al. Nanoencapsulation improves relative bioavailability and antipsychotic effect of olanzapine in rats
Lakkakula et al. Alginate‐based nanosystems for therapeutic applications
Osmani et al. Cyclodextrin nanosponges in drug delivery and nanotherapeutics
Singh et al. Chitosan nanoparticles: a versatile frontier in drug delivery and wound healing across multiple routes
CN106727430A (zh) 一种载药多孔纳米粒子的制备方法
JP2019513139A5 (enExample)
Lee et al. A charge-switched nano-sized polymeric carrier for protein delivery
Malhotra et al. Nanoneuroscience: cutting-edge approach for disease management
Zhu et al. Intranasal administration of pullulan-based nanoparticles for enhanced delivery of adriamycin into the brain: in vitro and in vivo evaluation
TWI543778B (zh) 蛋白質／石墨烯奈米複合藥物載體
Demina et al. Development strategies and biopharmaceutical aspects of drug delivery systems
CN111315399B (zh) 用于药物递送的葡萄糖敏感性组合物